MAPT and Alzheimer disease: The cerebrospinal fluid (CSF)’s sTREM2 levels raise with ageing and become further heightened in AD patients, correlating with the CSF levels of total Tau and p-Tau proteins, but not with CSF levels of Aβ42 [108,109].